Go Pro

PROCEPT BioRobotics (PRCT) Earnings Date, Estimates & Call Transcripts

PROCEPT BioRobotics logo
$20.41 +0.38 (+1.90%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$20.32 -0.09 (-0.47%)
As of 08/7/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PROCEPT BioRobotics Earnings Summary

PROCEPT BioRobotics announced Q2 2026 earnings on August 4, 2026, reporting an EPS of -$0.47, which missed analysts' consensus estimates of -$0.46 by $0.01. Quarterly revenue rose 19.3% year-over-year to $94.50 million, above the consensus estimate of $92.77 million. With a trailing EPS of -$1.94, PROCEPT BioRobotics' earnings are expected to grow next year, from ($1.67) to ($1.07) per share.

Latest Q2
Earnings Date
Aug. 4Estimated
Consensus EPS
(Aug. 4)
-$0.46
Actual EPS
(Aug. 4)
-$0.47 Missed By -$0.01
Actual Revenue
(Aug. 4)
$94.50M

Q2 2026 Earnings Resources

Get PROCEPT BioRobotics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PROCEPT BioRobotics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

PRCT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PRCT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

PROCEPT BioRobotics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue Guidance
Q1 20262-$0.39-$0.32-$0.36$93.7 M$79.0 M - $82.0 M
Q2 20262-$0.30-$0.26-$0.28$94.8 M$91.0 M - $95.0 M
Q3 20262-$0.27-$0.23-$0.25
Q4 20262-$0.20-$0.17-$0.19
FY 2026 8 -$1.16 -$0.98 -$1.07
Q1 20271-$0.18-$0.18-$0.18
Q2 20271-$0.10-$0.10-$0.10
Q3 20271-$0.13-$0.13-$0.13

PROCEPT BioRobotics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/4/2026Q2 2026-$0.4619-$0.47 -$0.0081-$0.47$92.77M$94.50M
4/29/2026Q1 2026-$0.55-$0.56 -$0.01-$0.56$80.52M$83.13M
2/25/2026Q4 2025-$0.32-$0.53 -$0.21-$0.53$93.70M$76.38M
11/4/2025Q3 2025-$0.41-$0.38+$0.03-$0.38$80.78M$83.33M
8/6/2025Q2 2025-$0.41-$0.35+$0.06-$0.35$75.67M$79.18M
4/24/2025Q1 2025-$0.49-$0.45+$0.04-$0.45$65.39M$69.16M
2/25/2025Q4 2024-$0.34-$0.35 -$0.01-$0.35$66.79M$68.24M
10/28/2024Q3 2024-$0.49-$0.40+$0.09-$0.40$53.30M$58.40M

PROCEPT BioRobotics Earnings - Frequently Asked Questions

PROCEPT BioRobotics (NASDAQ:PRCT) last announced its quarterly earning data on Tuesday, August 4, 2026. Learn more on PRCT's earnings history.

PROCEPT BioRobotics issued an update on its FY 2026 earnings guidance on Tuesday, August, 4th. The company issued revenue guidance of $390.0 million-$410.0 million, compared to the consensus revenue estimate of $397.2 million.

In the previous quarter, PROCEPT BioRobotics (NASDAQ:PRCT) missed the analysts' consensus estimate of ($0.46) by $0.01 with a reported earnings per share (EPS) of ($0.47). Learn more on analysts' earnings estimate vs. PRCT's actual earnings.

The conference call for PROCEPT BioRobotics' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for PROCEPT BioRobotics' latest earnings report can be read online.
Read Transcript

PROCEPT BioRobotics (NASDAQ:PRCT) has a recorded annual revenue of $308.05 million.

PROCEPT BioRobotics (NASDAQ:PRCT) has a recorded net income of -$95.57 million. PRCT has generated -$1.94 earnings per share over the last four quarters.

PROCEPT BioRobotics' earnings are expected to grow from ($1.67) per share to ($1.07) per share in the next year.


Earnings data for NASDAQ:PRCT is sourced from Fiscal.ai, with the most recent quarter reported on 8/4/2026. New results are added as companies report their earnings.
From Our Partners